Literature DB >> 30291292

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer.

Kazuto Harada1,2, Ahmed A F Abdelhakeem1, Jaffer A Ajani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30291292     DOI： 10.1038/s41571-018-0108-x

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.

Authors:  Lola Fashoyin-Aje; Martha Donoghue; Huanyu Chen; Kun He; Janaki Veeraraghavan; Kirsten B Goldberg; Patricia Keegan; Amy E McKee; Richard Pazdur
Journal:  Oncologist       Date:  2018-08-17

2.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Authors:  Alicia Latham; Preethi Srinivasan; Yelena Kemel; Jinru Shia; Chaitanya Bandlamudi; Diana Mandelker; Sumit Middha; Jaclyn Hechtman; Ahmet Zehir; Marianne Dubard-Gault; Christina Tran; Carolyn Stewart; Margaret Sheehan; Alexander Penson; Deborah DeLair; Rona Yaeger; Joseph Vijai; Semanti Mukherjee; Jesse Galle; Mark A Dickson; Yelena Janjigian; Eileen M O'Reilly; Neil Segal; Leonard B Saltz; Diane Reidy-Lagunes; Anna M Varghese; Dean Bajorin; Maria I Carlo; Karen Cadoo; Michael F Walsh; Martin Weiser; Julio Garcia Aguilar; David S Klimstra; Luis A Diaz; Jose Baselga; Liying Zhang; Marc Ladanyi; David M Hyman; David B Solit; Mark E Robson; Barry S Taylor; Kenneth Offit; Michael F Berger; Zsofia K Stadler
Journal:  J Clin Oncol       Date:  2018-10-30       Impact factor: 50.717
  2 in total
  1 in total

Review 1.  Immunotherapy use in oesophagogastric cancers-a review of the literature.

Authors:  Annabel Smith; Amitesh Roy; Christos S Karapetis; Vy Broadbridge; Timothy Price
Journal:  Br J Cancer       Date:  2022-03-08       Impact factor: 9.075
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.